Agilon Health, Inc. AGL
Institutional shares held
381 Million
2.09M
calls
2.17M
puts
Total value of holdings
$2.06B
$11.3M
calls
$11.7M
puts
Market Cap
$2.22B
410,936,000
Shares Out.
Institutional ownership
92.7%
# of Institutions
230
We take great care to ensure that the data presented and summarized in this overview for agilon health, inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AGL
View all-
Clayton, Dubilier & Rice, LLC100MShares$541 Million98.6% of portfolio
-
Wellington Management Group LLP Boston, MA56.8MShares$307 Million0.06% of portfolio
-
Morgan Stanley New York, NY54.6MShares$295 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA42.4MShares$229 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.9MShares$157 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA20.2MShares$109 Million0.03% of portfolio
-
Black Rock Inc. New York, NY14MShares$75.7 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.84MShares$47.8 Million1.41% of portfolio
-
State Street Corp Boston, MA5.18MShares$28.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.65MShares$25.2 Million0.0% of portfolio
Latest Institutional Activity in AGL
Top Purchases
Top Sells
About AGL
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Insider Transactions at AGL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2024
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,108
+42.44%
|
-
|
|
Apr 15
2024
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,041
+41.54%
|
-
|
|
Apr 15
2024
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
252,243
+42.86%
|
-
|
|
Apr 15
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,189
+28.07%
|
-
|
|
Apr 15
2024
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,189
+30.13%
|
-
|
|
Apr 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,056
-2.01%
|
$12,224
$4.95 P/Share
|
|
Apr 14
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-1.37%
|
$3,240
$4.95 P/Share
|
|
Apr 14
2024
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,978
-9.17%
|
$15,912
$4.95 P/Share
|
|
Apr 14
2024
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,875
-2.34%
|
$31,500
$4.95 P/Share
|
|
Apr 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,817
-0.96%
|
$19,268
$4.95 P/Share
|
|
Apr 14
2024
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,506
-1.21%
|
$22,024
$4.95 P/Share
|
|
Mar 14
2024
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,751
-13.47%
|
$33,755
$5.23 P/Share
|
|
Mar 14
2024
|
Timothy Bensley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,945
+22.97%
|
-
|
|
Mar 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,900
-1.57%
|
$24,500
$5.23 P/Share
|
|
Mar 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Open market or private purchase
|
Direct |
11,956
+3.7%
|
-
|
|
Mar 14
2024
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
95,266
-26.91%
|
$476,330
$5.23 P/Share
|
|
Mar 14
2024
|
Benjamin Shaker Chief Markets Officer |
BUY
Open market or private purchase
|
Direct |
274,455
+43.67%
|
-
|
|
Mar 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,883
-4.5%
|
$9,415
$5.23 P/Share
|
|
Mar 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
5,434
+11.5%
|
-
|
|
Mar 14
2024
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,883
-2.94%
|
$9,415
$5.23 P/Share
|
Last 12 Months Summary
Buy / Acquisition
2.52M
Shares
From
17
Insiders
| Exercise of conversion of derivative security | 1.33M shares |
|---|---|
| Open market or private purchase | 379K shares |
| Grant, award, or other acquisition | 813K shares |
Sell / Disposition
95M
Shares
From
12
Insiders
| Other acquisition or disposition | 438K shares |
|---|---|
| Open market or private sale | 94.4M shares |
| Payment of exercise price or tax liability | 137K shares |